Targeting Toll-Like Receptor Signaling Pathways for Design of Novel Immune Therapeutics

By  

Current Drug Discovery Technologies, Vol. 5, Iss. 1, 2008-03 ,pp. : 29-38

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Dopamine Signaling in the Striatum by Phosphodiesterase Inhibitors: Novel Therapeutics to Treat Neurological and Psychiatric Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 14, Iss. 2, 2014-09 ,pp. : 72-82

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Glycogen Synthase Kinase-3 in the CNS: Implications for the Development of New Treatments for Mood Disorders

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1399-1409

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Novel Therapeutics Targeting the Urokinase Plasminogen Activator Receptor (uPAR) and Their Translation Toward the Clinic

By  

Current Pharmaceutical Design, Vol. 17, Iss. 19, 2011-06 ,pp. : 1970-1978

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 76-86

Bentham Science Publishers

Access to resources Recommend Favorite